Characterization of porcine tumor necrosis factor receptor 2: Implications for xenotransplantation

被引:5
|
作者
Costa, C.
Casinghino, S. R.
Fodor, W. L.
机构
[1] Hosp Llobregat, Hosp Duran & Reynals, Inst DInvest Biomed & Bellvitge IDIBELL, Barcelona 08907, Spain
[2] Alexion Pharmaceut Inc, Dept Mol Sci, Cheshire, CT USA
[3] Hosp Llobregat, Inst Invest Biomed & Bellvitge, Barcelona, Spain
[4] Univ Connecticut, Dept Mol & Cellular Biol, CT Ctr Regenerat Biol, Storrs, CT USA
关键词
D O I
10.1016/j.transproceed.2007.07.077
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Clinical solid organ xenotransplantation is precluded by the strong immune response that results in rejection of pig xenografts in primate models. Innate immunity seems to play a major role in this process. In particular, tumor necrosis factor (TNF), produced by natural killer cells and macrophages, contributes to xenograft rejection by promoting endothelial cell activation and the recruitment of inflammatory cells. To further elucidate its molecular mechanism, we cloned the full-length cDNA of porcine TNF-Receptor 2 (pTNFR2, p75) by reverse transcriptase polymerase chain reaction (PCR) of total RNA isolated from porcine peripheral blood mononuclear cells. To this end, we used degenerate primers based on the sequences of the mouse, rat, and human homologues. Two PCR fragments were obtained that contained the pTNFR2 sequence, but differed in size. The shorter clones lacked the sequence corresponding to exon 4 by homology but identical for the rest, suggesting there is an alternative spliced mRNA variant of the porcine receptor. The predicted protein sequence (461 amino acids, containing exon 4) exhibited 72.5% identity to the human TNFR2 and 58.7% to the mouse molecule. By predicted protein sequence analysis, we determined that it comprised the four TNFR cysteine-rich repeats conserved between species. However, the molecule missing exon 4 lacks one cysteine-rich repeat. To assess function, we produced two recombinant proteins containing the extracellular domain of each pTNFR2 variant fused to the Fc portion of human IgG1. Next, we examined their ability to inhibit human TNF-mediated activation of porcine aortic endothelial cells. The addition of the whole pTNFR2 fusion protein to the TNF treatment blocked the up-regulation of activation markers. However, the fusion protein lacking exon 4 failed to effectively counteract TNF effects. These two pTNFR2 isoforms may play differential roles in the process of xenograft rejection.
引用
收藏
页码:2443 / 2446
页数:4
相关论文
共 50 条
  • [21] Tumor necrosis factor receptor superfamily
    Naismith, JH
    Sprang, SR
    JOURNAL OF INFLAMMATION, 1996, 47 (1-2) : 1 - 7
  • [22] Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis
    Yang, Nicole
    Huang, Jie
    Frits, Michelle
    Iannaccone, Christine
    Weinblatt, Michael E.
    Rifai, Nader
    Shadick, Nancy
    Bradwin, Gary
    Liao, Katherine P.
    PRACTICAL LABORATORY MEDICINE, 2019, 16
  • [23] Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2
    Roman Fischer
    Jessica Marsal
    Cristiano Guttà
    Stephan A. Eisler
    Nathalie Peters
    John R. Bethea
    Klaus Pfizenmaier
    Roland E. Kontermann
    Scientific Reports, 7
  • [24] Function and regulation of tumor necrosis factor receptor type 2
    Carpentier, I
    Coornaert, B
    Beyaert, R
    CURRENT MEDICINAL CHEMISTRY, 2004, 11 (16) : 2205 - 2212
  • [25] Roles of Tumor Necrosis Factor-α and Tumor Necrosis Factor-α Receptor 2 in Inflammation-Related Diseases
    Memon, Nazakat Hussain
    Khan, Maaz
    Memon, Muhammad Raza
    Lanjwani, Abdul Hameed
    Kandhro, Farhatullah
    Laghari, Arshad Hussain
    Arain, Sadia Qamar
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (52A) : 234 - 245
  • [26] Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2
    Fischer, Roman
    Marsal, Jessica
    Gutta, Cristiano
    Eisler, Stephan A.
    Peters, Nathalie
    Bethea, John R.
    Pfizenmaier, Klaus
    Kontermann, Roland E.
    SCIENTIFIC REPORTS, 2017, 7
  • [27] Estradiol Modulates Tumor Necrosis Factor-Induced Endothelial Inflammation: Role of Tumor Necrosis Factor Receptor 2
    Chakrabarti, Subhadeep
    Davidge, Sandra T.
    JOURNAL OF VASCULAR RESEARCH, 2013, 50 (01) : 21 - 34
  • [28] TUMOR NECROSIS FACTOR RECEPTOR 2 REGULATES EPITHELIAL HOMEOSTASIS
    Girish, Nandini
    Punit, Shivesh
    Liu, Cambrian Y.
    Washington, Kay
    Polk, D. Brent
    GASTROENTEROLOGY, 2019, 156 (06) : S66 - S67
  • [29] association of tumor necrosis factor alpha, lymphotoxin alpha, tumor necrosis factor receptor 1 and tumor necrosis factor receptor 2 gene polymorphisms and serum levels with periodontitis and type 2 diabetes in Serbian population
    Petrovic, Sanja Matic
    Nikolic, Nadja
    Toljic, Bosko
    Arambasic-Jovanovic, Jelena
    Milicic, Biljana
    Milicic, Tanja
    Jotic, Aleksandra
    Vidakovic, Melita
    Milasin, Jelena
    Pucar, Ana
    ARCHIVES OF ORAL BIOLOGY, 2020, 120
  • [30] Balancing Tumor Necrosis Factor Receptor I and Tumor Necrosis Factor Receptor II Jointly for Joint Inflammation
    Aggarwal, Bharat B.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (10) : 2657 - 2660